Patterns of tobacco use in low and middle income countries by tobacco product and sociodemographic characteristics: nationally representative survey data from 82 countries.

Journal: BMJ (Clinical research ed.)

Volume: 378

Issue: 

Year of Publication: 2022

Affiliated Institutions:  Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany. Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Department of Economics and Centre for Modern Indian Studies, University of Goettingen, Göttingen, Germany. RWI-Leibniz Institute for Economic Research, Essen (Berlin Office), Germany. Quantitative Sciences Unit and Department of Pediatrics, Stanford University, Stanford, CA, USA. Port of Spain, Trinidad and Tobago. St Francis Hospital, Kampala, Uganda. Ministry of Health, Victoria, Seychelles. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. National Institute for Medical Research, Dar es Salaam, Tanzania. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya. Non-Communicable Disease Department, National Center for Disease Control and Public Health, Tbilisi, Georgia. Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA. MRC/Wits Rural Public Health and Health Transitions Research Unit, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa. Division of Primary Care and Population Health, Stanford University, Stanford, CA, USA.

Abstract summary 

To determine the prevalence and frequency of using any tobacco product and each of a detailed set of tobacco products, how tobacco use and frequency of use vary across countries, world regions, and World Bank country income groups, and the socioeconomic and demographic gradients of tobacco use and frequency of use within countries.Secondary analysis of nationally representative, cross-sectional, household survey data from 82 low and middle income countries collected between 1 January 2015 and 31 December 2020.Population based survey data.1 231 068 individuals aged 15 years and older.Self-reported current smoking, current daily smoking, current smokeless tobacco use, current daily smokeless tobacco use, pack years, and current use and use frequencies of each tobacco product. Products were any type of cigarette, manufactured cigarette, hand rolled cigarette, water pipe, cigar, oral snuff, nasal snuff, chewing tobacco, and betel nut (with and without tobacco).The smoking prevalence in the study sample was 16.5% (95% confidence interval 16.1% to 16.9%) and ranged from 1.1% (0.9% to 1.3%) in Ghana to 50.6% (45.2% to 56.1%) in Kiribati. The user prevalence of smokeless tobacco was 7.7% (7.5% to 8.0%) and prevalence was highest in Papua New Guinea (daily user prevalence of 65.4% (63.3% to 67.5%)). Although variation was wide between countries and by tobacco product, for many low and middle income countries, the highest prevalence and cigarette smoking frequency was reported in men, those with lower education, less household wealth, living in rural areas, and higher age.Both smoked and smokeless tobacco use and frequency of use vary widely across tobacco products in low and middle income countries. This study can inform the design and targeting of efforts to reduce tobacco use in low and middle income countries and serve as a benchmark for monitoring progress towards national and international goals.

Authors & Co-authors:  Theilmann Lemp Winkler Manne-Goehler Marcus Probst Lopez-Arboleda Ebert Bommer Mathur Andall-Brereton Bahendeka Bovet Farzadfar Ghasemi Mayige Saeedi Moghaddam Mwangi Naderimagham Sturua Atun Davies Bärnighausen Vollmer Geldsetzer

Study Outcome 

Source Link: Visit source

Statistics
Citations :  GBD 2019 Risk Factors Collaborators . Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1223-49. 10.1016/S0140-6736(20)30752-2 
Authors :  25
Identifiers
Doi : e067582
SSN : 1756-1833
Study Population
Male,Female
Mesh Terms
Cross-Sectional Studies
Other Terms
Study Design
Study Approach
Country of Study
Guinea
Publication Country
England